Income Statement
ZURA BIO LTD
ZURA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
75.25 | 55.19 | 62.64 | 2.29 | 0.00 |
|
Research & Development
|
42.08 | 24.40 | 44.00 | - | - |
|
Selling, General & Administrative
|
33.16 | 30.79 | 18.64 | 2.29 | - |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-75.25 | -55.19 | -62.64 | -2.29 | - |
|
Non-Operating Income
|
6.60 | 2.79 | -2.08 | 6.22 | - |
|
Interest Income
|
6.34 | 8.00 | 2.19 | 0.00 | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
- | - | 2.08 | - | - |
|
Income Before Tax
|
-68.65 | -52.40 | -60.56 | - | - |
|
Income Tax Expense
|
0.00 | 0.00 | -0.20 | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-68.65 | -52.40 | -60.36 | 3.55 | - |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-75.20 | -55.18 | -62.64 | -2.29 | 0.00 |
|
Earnings Per Share (Basic)
|
-1.06 | -0.60 | -2.09 | 0.21 | - |
|
Diluted EPS
|
-1.06 | -0.60 | -2.09 | 0.21 | - |
|
Weighted Average Shares
|
94.16 | 75.07 | 33.06 | 13.80 | - |
|
Diluted Weighted Avg Shares
|
94.16 | 75.07 | 33.06 | 13.80 | - |
|
Comprehensive Income
|
- | - | - | - | - |